- $6.41m
- $9.52m
- $4.92m
- 54
- 41
- 65
- 52
Annual cashflow statement for Stemtech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 August 31st | 2020 August 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 15 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.034 | -0.034 | -7.11 | -8.63 | -5.43 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.014 | 0.015 | 3.79 | 7.3 | 1.72 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.005 | -0.048 | 0.973 | -0.336 | 1.09 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.011 | -0.066 | -1.91 | -1.22 | -2.04 |
Capital Expenditures | 0 | 0 | — | — | — |
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 0 | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | 0 | 0 | 0 | — | — |
Financing Cash Flow Items | — | — | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.004 | 0.068 | 2.63 | 0.339 | 1.58 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.008 | 0.002 | 0.695 | -0.696 | -0.018 |